v3.25.4
Statements of Changes in Shareholders’ Deficit - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jul. 11, 2024
Balance (in Shares) at Jul. 11, 2024        
Issuance of Class B ordinary shares to Sponsor [1] $ 606 24,394 25,000
Issuance of Class B ordinary shares to Sponsor (in Shares) [1] 6,059,925      
Share-based compensation expense to independent director nominees 81,750 81,750
Net income (loss) (157,572) (157,572)
Balance at Dec. 31, 2024 $ 606 106,144 (157,572) (50,822)
Balance (in Shares) at Dec. 31, 2024 6,059,925      
Sale of 555,000 Private Placement Units $ 56 5,549,944 5,550,000
Sale of 555,000 Private Placement Units (in Shares) 555,000        
Fair value of Public Warrants at issuance 1,222,500 1,222,500
Allocated value of transaction costs to Private Placement shares, Public Warrants and over-allotment liability (103,379) (103,379)
Accretion of Class A ordinary shares to redemption amount (6,775,209) (10,072,926) (16,848,135)
Net income (loss) 5,306,976 5,306,976
Balance at Dec. 31, 2025 $ 56 $ 606 $ (4,923,522) $ (4,922,860)
Balance (in Shares) at Dec. 31, 2025 555,000 6,059,925      
[1] On October 2, 2024, the Company, through a share capitalization, issued the Sponsor an additional 1,747,425 Class B ordinary shares as bonus shares, as a result of which the Sponsor has purchased an aggregate of 6,059,925 Class B ordinary shares. All share and per share data has been retrospectively presented.